. 2021 Oct 5;29(1):60–68. doi: 10.1111/jvh.13615

TABLE 2.

Factors associated with HBV testing during routine HIV care

		n/N	Univariable analysis		Multivariable analysis
		n/N	OR (95% CI)	p	OR (95% CI)	p
Sex	Male	158/385	1.00	0.01	1.00	0.02
Sex	Female	229/689	0.72 (0.55–0.93)		0.71 (0.54–0.94)	0.02
Age group, years	18–40	149/339	1.00	<0.001	1.00	0.01
Age group, years	>40	237/730	0.61 (0.47–0.80)		0.69 (0.51–0.92)	0.01
WHO stage at presentation (n[%])	I–II	152/380	1.00	0.62
WHO stage at presentation (n[%])	III–IV	215/560	0.79 (0.57–1.09)
CD4 at ART initiation, cells/mm³ (n[%])	<200	187/474	1.00	0.23
CD4 at ART initiation, cells/mm³ (n[%])	200+	129/294	1.19 (0.89–1.61)
Period of ART initiation, years (n[%])	1998–2013	170/632	1.00	<0.001	1.00	<0.001
Period of ART initiation, years (n[%])	2014–2019	213/387	3.33 (2.55–4.34)		3.02 (2.27–4.00)	<0.001
ART line regimen	1st line	334/841	1.00	0.01	1.00	0.26
ART line regimen	2nd/3rd line	47/164	0.61 (0.42–0.88)		0.80 (0.54–1.18)	0.26

Abbreviations: ART, antiretroviral treatment; CI, confidence interval; OR, odds ratio; WHO, world health organization.